Literature DB >> 19378426

Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris.

S Solheim1, H K Grøgaard, P Hoffmann, H Arnesen, Ingebjørg Seljeflot.   

Abstract

OBJECTIVE: To investigate the profile of circulating inflammatory markers after percutaneous coronary intervention (PCI) in patients with AMI or stable angina pectoris (AP).
MATERIAL AND METHODS: Twenty patients with AMI and 10 with stable AP were treated with PCI of a central coronary artery. Blood samples were drawn immediately before PCI, in the AP group and after 3 and 12 h, days 1, 3, 5, 7 and 14 in both groups.
RESULTS: Interleukin 6 increased in both groups to time-point 12 h and day 1 (peak), being significantly higher in the AMI group compared to the AP group at 3 and 12 h, and also at days 1 and 3. A similar profile was demonstrated for CRP with significantly higher levels in the AMI group at days 1, 3 and 5 compared to the AP group. A slightly different pattern was shown for Interleukin 10 (IL-10) with significantly higher levels in the AMI group at 3 and 12 h, days 1 and 14 compared to the AP group.
CONCLUSION: AMI patients treated with PCI experienced a marked short-term increase in pro-inflammatory mediators as well as IL-10 compared to patients with stable angina pectoris treated with PCI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19378426     DOI: 10.1080/00365510701884584

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  6 in total

1.  Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study.

Authors:  Eva C Knudsen; Ingebjørg Seljeflot; Abdelnoor Michael; Jan Eritsland; Arild Mangschau; Carl Müller; Harald Arnesen; Geir Ø Andersen
Journal:  Cardiovasc Diabetol       Date:  2010-09-02       Impact factor: 9.951

2.  IL-6 signalling in patients with acute ST-elevation myocardial infarction.

Authors:  Vibeke N Ritschel; Ingebjørg Seljeflot; Harald Arnesen; Sigrun Halvorsen; Thomas Weiss; Jan Eritsland; Geir Ø Andersen
Journal:  Results Immunol       Date:  2013-12-14

3.  Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure.

Authors:  Trygve Husebye; Jan Eritsland; Harald Arnesen; Reidar Bjørnerheim; Arild Mangschau; Ingebjørg Seljeflot; Geir Øystein Andersen
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

4.  The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris.

Authors:  Ragnhild Helseth; Svein Solheim; Harald Arnesen; Ingebjørg Seljeflot; Trine Baur Opstad
Journal:  Mediators Inflamm       Date:  2016-12-15       Impact factor: 4.711

5.  The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention.

Authors:  Ragnhild Helseth; Svein Solheim; Trine Opstad; Pavel Hoffmann; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Mediators Inflamm       Date:  2014-03-11       Impact factor: 4.711

6.  Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction.

Authors:  Jasveen J Kandhai-Ragunath; Carine J M Doggen; Liefke C van der Heijden; Marlies M Kok; Paolo Zocca; Bjorn de Wagenaar; Cees Doelman; Harald T Jørstad; Ron J G Peters; Clemens von Birgelen
Journal:  Heart Vessels       Date:  2018-03-14       Impact factor: 2.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.